SPOTLIGHT -
Slideshow
Author(s):
Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.
Investigating the SAINT iTBS Protocol for Bipolar I Depression
Blue Light Blockers: A Behavior Therapy for Mania
Improving Sleep to Treat Resistant Depression in Older Adults
Blue Light, Depression, and Bipolar Disorder
Clinical Features Associated With Response to Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression
Phase 2 Clinical Trial of AL001 for Major Depressive Disorder: Initiation Date Set for Late 2025